查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太機器人神經外科市場：分析與預測（2025-2035）
市場調查報告書
商品編碼
1781121

亞太機器人神經外科市場：分析與預測（2025-2035）

Asia-Pacific Robotic Neurosurgery Market: Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 71 Pages | 商品交期: 1-5個工作天內

價格

亞太地區機器人神經外科市場規模預計將從 2025 年的 9,260 萬美元增至 2035 年的 5.87 億美元，預測期內的複合年成長率為 20.28%。

該地區神經系統疾病發生率的上升推動了機器人神經外科手術的擴張，也增加了對先進精準手術技術的需求。人工智慧、即時影像技術的融合以及精準度的提升等技術創新正在顯著改善手術效果，並拓展手術技術的可能性。

主要市場統計數據
預測期 2025-2035
2025年評估 9260萬美元
2035年預測 5.87億美元
複合年成長率 20.28%

微創手術日益普及，進一步加速了機器人神經外科手術的普及，因為這些手術降低了手術風險並縮短了患者的恢復時間。此外，該地區快速發展的醫療基礎設施，尤其是在新興經濟體，也為其應用創造了有利的環境。此外，本地和國際公司之間日益成長的策略夥伴關係以及不斷增加的研發投入，正在刺激技術創新並擴大市場准入。這使得機器人神經外科手術成為該地區的關鍵成長領域。

該地區的機器人神經外科手術市場已成為成長最快的外科手術機器人領域之一。腦腫瘤、癲癇和帕金森氏症等神經系統疾病的發生率不斷上升，推動了對先進、高精度外科手術的需求。對於該地區（無論是已開發經濟體還是新興經濟體）的醫療保健專業人士而言，機器人神經外科手術因其高精度、微創性和改善患者預後的優勢，已成為一個頗具吸引力的選擇。

人工智慧、即時影像處理和觸覺回饋設備等技術的發展，改善了操作員的控制和視覺化，正在徹底改變神經外科。微創手術具有恢復時間更短、併發症更少、住院時間更短等優勢，因此也推動了機器人系統的普及。

新興經濟體，尤其是中國、印度和東南亞，正在大力投資醫療基礎設施，政府的支持和私營部門的創新加速了市場滲透。此外，本地公司正在開發符合當地需求、價格合理的機器人系統，這有助於提高先進神經外科治療的可近性。在臨床應用不斷擴展和報銷機制更加優惠的推動下，亞太地區機器人神經外科市場預計將在長期內實現顯著成長。

市場區隔:

細分 1：按產品類型

  • 機器人系統
  • 服務
  • 設備和配件

細分2：按地區

  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 其他

本報告研究了亞太地區的機器人神經外科市場，並總結了主要趨勢、市場影響因素分析、法律制度、技術和專利分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局和主要企業的概況。

目錄

執行摘要

範圍和定義

第1章 機器人神經外科市場：產業展望

  • 趨勢：現況與未來影響評估
    • 機器人神經外科手術的採用率不斷提高
    • 公司之間開展了許多合作
    • 增加產品發布和監管核准
  • 供應鏈概覽
  • 法律規範
    • 日本
    • 中國
  • 定價分析
    • 案例研究：Brain Navi 的 NaoTrac 完成 100 例神經外科手術
  • 資金籌措方案
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機會

第 2 章：機器人神經外科手術市場（按地區）

  • 區域摘要
  • 亞太地區
    • 區域概況
    • 市場成長動力
    • 市場問題
    • 治療次數
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他

第3章市場：競爭基準化分析與公司概況

  • 產品基準
  • 關鍵策略和發展
  • 公司簡介
    • KUKA AG (Midea Group)
    • Beijing Baihui Weikang Technology Co., Ltd.
    • Brain Navi Biotechnology Co. Ltd
    • Beijing Tinavi Medical Technologies Co., Ltd.

第4章調查方法

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Robotic Neurosurgery Market

The Asia-Pacific robotic neurosurgery market is projected to reach $587.0 million in 2035 and estimated $92.6 million in 2025, growing at a CAGR of 20.28% during the forecast period 2025-2035. The rising prevalence of neurological conditions in the APAC area is fuelling the expansion of robotic neurosurgery and raising the need for sophisticated and accurate surgical techniques. Technological developments are greatly enhancing surgical results and increasing procedural capabilities. Examples of these developments include AI integration, real-time imaging, and improved precision.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$92.6 Million
2035 Forecast$587.0 Million
CAGR20.28%

The increasing popularity of minimally invasive procedures is speeding up adoption even more because they lower surgical risks and recuperation periods for patients. Additionally, a favourable deployment environment is being created by the rapid expansion of healthcare infrastructure throughout emerging APAC markets. Furthermore, increasing R&D expenditures and strategic partnerships between regional and international businesses are stimulating innovation and expanding market accessibility, making robotic neurosurgery a vital area of expansion in the healthcare sector in Asia-Pacific.

Market Introduction

The Asia-Pacific (APAC) robotic neurosurgery industry is emerging as one of the region's fastest-growing surgical robotics segments. The need for sophisticated, high-precision surgical procedures is growing as neurological conditions like brain tumours, epilepsy, and Parkinson's disease become more common. Healthcare professionals in both established and developing APAC nations find robotic neurosurgery to be a tempting alternative due to its increased accuracy, decreased invasiveness, and improved patient outcomes.

Technological developments that provide surgeons more control and visualisation, such as the incorporation of artificial intelligence, real-time imaging, and haptic feedback devices, are transforming neurosurgery procedures. The deployment of robotic systems is being further fuelled by the region's trend towards minimally invasive surgeries, which have advantages like quicker recovery times, less problems, and shorter hospital stays.

Market penetration is being accelerated by rising investments in healthcare infrastructure, especially in developing nations like China, India, and Southeast Asia, as well as encouraging government programs and rising private-sector innovation. Furthermore, local producers are creating affordable robotic systems that are suited to local requirements, increasing access to cutting-edge neurosurgical treatment. The market for robotic neurosurgery in APAC is expected to increase significantly over the long run due to expanding clinical applications and better reimbursement regulations.

Market Segmentation

Segmentation 1: by Product Type

  • Robotic Systems
  • Services
  • Instruments and Accessories

Segmentation 2: by Region

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

APAC Robotic Neurosurgery Market Trends, Drivers and Challenges

Market Trends

  • APAC is the fastest-growing region in the global robotic neurosurgery market, with a strong CAGR projection.
  • Increasing adoption of robotic neurosurgery in ambulatory surgical centers and specialty clinics.
  • Surge in domestic robotic system development by regional players, leading to more affordable solutions.
  • Growing demand for minimally invasive and AI-integrated neurosurgical procedures.
  • Broader procedural applications such as spinal surgeries, brain tumor removal, and deep brain stimulation.

Key Drivers

  • Rising prevalence of neurological disorders like stroke, brain tumors, and Parkinson's disease.
  • Expanding healthcare infrastructure and increasing healthcare investments across APAC.
  • Advancements in surgical robotics, including improved imaging, navigation, and AI-powered systems.
  • Cost-effective robotic systems developed by regional players expanding accessibility.
  • Increasing number of trained neurosurgeons and improved medical education frameworks.

Major Challenges

  • High capital investment and maintenance costs limit adoption, especially in smaller hospitals.
  • Limited or inconsistent reimbursement policies across APAC countries.
  • Shortage of skilled professionals trained in robotic neurosurgery.
  • Complex and fragmented regulatory pathways across different countries in the region.
  • Rapid technological evolution creates pressure for frequent system upgrades.
  • Safety, ethical, and liability concerns related to robotic-assisted surgeries.

How can this report add value to an organization?

Product/Innovation Strategy: The APAC robotic neurosurgery market has been extensively segmented based on various categories, such as product type, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The APAC robotic neurosurgery market has numerous established players with product and service portfolios. Key players in the APAC robotic neurosurgery market, as analyzed and profiled in the study, include established companies offering robotic neurosurgery systems, instruments, accessories, and services.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

  • KUKA AG (Midea Group)
  • Beijing Baihui Weikang Technology Co., Ltd.
  • Brain Navi Biotechnology Co. Ltd
  • Beijing Tinavi Medical Technologies Co., Ltd.

Table of Contents

Executive Summary

Scope and Definition

1 Robotic Neurosurgery Market: Industry Outlook

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
    • 1.1.2 Significant Number of Collaborations among Market Players
    • 1.1.3 Growing Number of Product Launch and Regulatory Approvals
  • 1.2 Supply Chain Overview
  • 1.3 Regulatory Framework
    • 1.3.1 Japan
    • 1.3.2 China
  • 1.4 Pricing Analysis
    • 1.4.1 Case Study: Brain Navi's NaoTrac Reaches 100 Neurosurgical Procedures Milestone
  • 1.5 Funding Scenario
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
      • 1.6.1.2 Rising Prevalence of Neurological Disorders
      • 1.6.1.3 Continuous Technological Advancements in Robotic Neurosurgery
    • 1.6.2 Market Restraints
      • 1.6.2.1 High Cost of Investment
      • 1.6.2.2 Lack of Skilled Professionals
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems

2 Robotic Neurosurgery Market (by Region), $Million, 2023-2035

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Procedure Volume
    • 2.2.5 China
    • 2.2.6 Japan
    • 2.2.7 India
    • 2.2.8 Australia
    • 2.2.9 South Korea
    • 2.2.10 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Product Benchmarking
  • 3.2 Key Strategies and Development
  • 3.3 Company Profiles
    • 3.3.1 KUKA AG (Midea Group)
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personal
      • 3.3.1.6 Analyst View
    • 3.3.2 Beijing Baihui Weikang Technology Co., Ltd.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personal
      • 3.3.2.6 Analyst View
    • 3.3.3 Brain Navi Biotechnology Co. Ltd
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personal
      • 3.3.3.6 Analyst View
    • 3.3.4 Beijing Tinavi Medical Technologies Co., Ltd.
      • 3.3.4.1 Overview
      • 3.3.4.2 Top Products/Product Portfolio
      • 3.3.4.3 Top Competitors
      • 3.3.4.4 Target Customers
      • 3.3.4.5 Key Personal
      • 3.3.4.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Robotic Neurosurgery Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Asia-Pacific Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
  • Figure 3: Supply Chain and Risks within the Supply Chain
  • Figure 4: Japan Federation of Medical Devices Associations (JFMDA) Classification
  • Figure 5: NMPA Classification
  • Figure 6: Robotic Neurosurgery Market, Patent Analysis (by Year), January 2019-April 2025
  • Figure 7: Impact Analysis of Market Navigating Factors, 2024-2035
  • Figure 8: Incidences of Neurological Disorders, Thousands, 2018-2021
  • Figure 9: Prevalence of Neurological Disorders (by Type of Neurological Disease), Thousands, 1990-2019
  • Figure 10: Prevalence of Parkinson's Disease, Region (2016-2021)
  • Figure 11: Timeline of the FDA Approvals for Various Robotic Neurosurgery Systems
  • Figure 12: Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 13: Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 14: Asia-Pacific Robotic Neurosurgery Market, Installed Base, 2023-2035
  • Figure 15: Asia-Pacific Robotic Neurosurgery Market, Unit Sold, 2023-2035
  • Figure 16: Incidences of Neurological Disorders in China, 2018-2021
  • Figure 17: China Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 18: China Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 19: Incidences of Neurological Disorders in Japan, 2018-2021
  • Figure 20: Japan Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 21: Japan Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 22: Incidences of Neurological Disorders in India, 2018-2021
  • Figure 23: India Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 24: India Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 25: Incidences of Neurological Disorders in Australia, 2018-2021
  • Figure 26: Australia Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 27: Australia Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 28: Incidences of Neurological Disorders in South Korea, 2018-2021
  • Figure 29: South Korea Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 30: South Korea Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 31: Rest-of-Asia-Pacific Robotic Neurosurgery Market, Procedure Volume, 2023-2035
  • Figure 32: Rest-of-Asia-Pacific Robotic Neurosurgery Market, $Million, 2023-2035
  • Figure 33: Strategic Initiatives, January 2022-April 2025
  • Figure 34: Data Triangulation
  • Figure 35: Top-Down and Bottom-Up Approach
  • Figure 36: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Robotic Neurosurgery Market Trend Analysis
  • Table 4: Some of the Partnerships and Collaborations in the Robotic Neurosurgery Market
  • Table 5: Some of the Product Launch and Regulatory Approvals in the Robotic Neurosurgery Market
  • Table 6: Medical Devices in Japan
  • Table 7: Costs of Neurosurgery Robotic Systems
  • Table 8: Funding Scenario of Neurosurgery Robotic Systems
  • Table 9: Comparison of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
  • Table 10: Comparison Between Various Navigation Systems Cost Breakdown of Robotic Neurosurgery Systems
  • Table 11: Robotic Neurosurgery Market (by Region), $Million, 2023-2035
  • Table 12: Asia-Pacific Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
  • Table 13: Incidences of Neurological Disorders in China, By Disease Type, 2018-2021
  • Table 14: Incidences of Neurological Disorders in Japan, By Disease Type, 2018-2021
  • Table 15: Incidences of Neurological Disorders in India, By Disease Type, 2018-2021
  • Table 16: Incidences of Neurological Disorders in Australia, By Disease Type, 2018-2021
  • Table 17: Incidences of Neurological Disorders in South Korea, By Disease Type, 2018-2021
  • Table 18: Robotic Neurosurgery Market, Product Benchmarking (by Product)
  • Table 19: Key Strategies, January 2022-April 2025